Tracked deals
9
9 tracked deals across 2022-2026.
Farmington, Connecticut, United States
Formerly known as BroadcastMed, BroadcastMed (Now Conexiant), BroadcastMed is now Conexiant
Healthcare media and intelligence company producing, promoting, and distributing clinical content to healthcare professionals, with associated education and network/connectivity capabilities.
Tracked deals
9
9 tracked deals across 2022-2026.
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Buyout
6 buyout · 3 addon
Last 5 years
Supporting Data
MJH Life Sciences, a privately held health care engagement network, has acquired the Rheumatology Winter Clinical Symposium (RWCS) and launched a dedicated rheumatology digital platform to expand year‑round specialty engagement. The annual RWCS meeting will continue under MJH's ownership with Physicians' Education Resource (PER) serving as the CME provider and HCPLive as a content partner to extend reach within the rheumatology community.
MJH Life Sciences has acquired BPD Healthcare, a tech-enabled marketing and communications partner for health systems and healthcare innovators. The acquisition, completed Oct. 22, 2025 with terms undisclosed, expands MJH's capabilities in data-driven marketing, communications and strategic advisory services; WindRose Health Investors sold its stake in BPD.
MJH Life Sciences has acquired the EnVision Summit, a certified continuing medical education (CME) conference for ophthalmologists held annually in Puerto Rico. The summit will be integrated into MJH's Physicians' Education Resource portfolio and supported by MJH's eye care brands to expand its ophthalmology education offerings.
BroadcastMed, supported by growth capital partner 424 Capital, has acquired Texere Publishing Ltd., a UK-based B2B media business serving scientific and healthcare markets. The acquisition expands BroadcastMed's global reach to over 3 million healthcare professionals and provides an exit for Texere's investors Mercia and AXM Venture Capital.
BroadcastMed has acquired Harborside, a medical publishing and communications leader specializing in oncology, expanding BroadcastMed’s reach across healthcare specialties and strengthening its oncology communications capabilities. The transaction was backed by growth equity partner 424 Capital and expands BroadcastMed’s total reach to over 2.8 million healthcare professionals.
BroadcastMed has acquired AEGIS Dental Network, a dental communications and publishing platform, adding 400,000 dental clinicians to its audience and expanding its clinical-education and multimedia offerings. The transaction was backed by growth capital partner 424 Capital and represents an add-on to BroadcastMed's PE-backed platform to broaden its reach into the dental market.
BroadcastMed, a healthcare-focused media company, has acquired PentaVision, a publishing leader in ophthalmology, optometry and opticianry. The acquisition—backed by growth investor 424 Capital—expands BroadcastMed’s reach into vision-care audiences and strengthens its clinical content and events offerings for eye care professionals.
MJH Life Sciences acquired Cannabis Science Conference (CSC Events, LLC), bringing the bi-annual scientific and medical cannabis events into its cannabis media and events portfolio. Founder Josh Crossney will remain in a leadership role as Director of Cannabis Events while the conference joins MJH's existing cannabis-focused platforms to expand education and outreach.
BroadcastMed, a healthcare intelligence and clinical-content company, has acquired Digitell, a virtual and hybrid event platform and full-service production company, to expand its event production capabilities and invest in Digitell's OPUS DX platform. The combined organization will broaden BroadcastMed's service offerings, deepen analytics and AI-driven audience insights, and extend reach into a larger pool of healthcare professionals.
Turn tracked acquisition activity into an outreach-ready buyer list.